Managing Your Due Diligence Process Throughout the Life Cycle of a Life Sciences Company
December 4, 2007
Ensuring top value of a product throughout the lifecycle process involves managing issues related to evaluating a potential product; Identifying the best people for a project, recognizing key value factors of a product, and managing the size, flow and duration of a project. This panel will specifically address:
- How does your evaluation of a project differ in the big Pharma setting vs. a more entrepreneurial setting?
- What factors do you consider in determining whether their will be life after the patent on the active
- How have considerations changed in doing research (basic and developmental) in the last 10 years?
- What are some sources for evaluating the likelihood of success of a project?
Panelists include: Kim Graham, Former Director, Cambridge Antibody Technology Inc.; Ed LeFevre, Partner, Foley; Roberto Rosenkranz, Ph.D., Chairman and CEO, ROXRO PHARMA; and L. James Strand, M.D., General Partner, Managing Director, Institutional Venture Partners (IVP).
Related Insights
May 28, 2025
Foley Viewpoints
U.S. and International Antitrust Agencies Signal Aggressive Antitrust Enforcement in Procurement, Consumer Products, and Labor Markets
As we previously reported on April 15 and April 28, the Department of Justice (DOJ) and Federal Trade Commission (FTC) are increasingly…
May 28, 2025
Foley Career Perspectives
Foley AANHPI Heritage Month Program: A Conversation With Crypto Journalist Laura Shin
In celebration of Asian American, Native Hawaiian, and Pacific Islander (AANHPI) Heritage Month, Foley & Lardner hosted a firmwide…
June 7, 2025
Events
HCCA Orange County Regional Healthcare Compliance Conference
Foley partner Judy Waltz, chair of the firm’s Health Care Practice Group, is speaking at the Health Care Compliance Association’s Orange County Regional Healthcare Compliance Conference on June 7.